Clinical and biochemical response following withdrawal of a long‐acting, depot injection form of octreotide (Sandostatin‐LAR®)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Premature mortality due to cardiovascular disease in hypopituitarism
1990 • 1,424 citations
Octreotide
1996 • 956 citations
Epidemiology and Long‐term Survival in Acromegaly: A Study of 166 Cases Diagnosed between 1955 and 1984
1988 • 591 citations
Mortality in acromegaly.
1970 • 479 citations
An audit of outcome of treatment in acromegaly
1993 • 476 citations
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
1980 • 468 citations
Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide
1991 • 234 citations
Treatment of Acromegaly with Dopamine Agonists
1992 • 222 citations
Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure
1996 • 200 citations
Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide1
1997 • 177 citations
Sandostatin LAR in Acromegalic Patients: Long Term Treatment
1997 • 174 citations
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
1995 • 151 citations
Long‐term therapy with long‐acting octreotide (Sandostatin‐LAR®) for the management of acromegaly
1998 • 139 citations
Long Term Effect of Incremental Doses of the Somatostatin Analog SMS 201–995 in 58 Acromegalic Patients*
1990 • 134 citations
Long‐term follow‐up of patients with hyperprolactinaemia
1996 • 132 citations
Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study [published erratum appears in J Clin Endocrinol Metab 1995 Nov;80(11):3238]
1995 • 122 citations
Octreotide Long-Acting Release (LAR)
1997 • 122 citations
Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly.
1993 • 118 citations
Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide
1997 • 99 citations
The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly
1995 • 89 citations
Hyperprolactinemia
1983 • 81 citations
Sandostatin LAR in Acromegalic Patients: Long Term Treatment
1997 • 62 citations
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly
1995 • 52 citations
Pharmacokinetics and efficacy of a long-acting formulation of the new somatostatin analog BIM 23014 in patients with acromegaly
1993 • 44 citations
As the Workforce Ages: Costs, Benefits, and Policy Challenges.
1994 • 8 citations
Depot Somatostatin Analogs--A New First Line Therapy for Acromegaly
1997 • 3 citations